Rare diseases
Investigational molecules
Locations
Back to Portugal673 clinical trials in Almada, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study of Tarlatamab for Patients with Limited-Stage Small-Cell Lung Cancer After Chemoradiotherapy
PortugalStudy of Ibrutinib and Rituximab for Patients with Untreated Marginal Zone Lymphoma
PortugalStudy of TAR-200 and Cetrelimab for Patients with Muscle-Invasive Bladder Cancer Not Undergoing Radical Cystectomy
PortugalStudy of Immunotherapy Combinations with GSK4428859, Dostarlimab, and GSK6097608 for Patients with Advanced Non-Small Cell Lung Cancer
PortugalStudy of Disitamab Vedotin and Pembrolizumab for Patients with Untreated Advanced Urothelial Cancer Expressing HER2
PortugalStudy on the Effectiveness and Safety of Pirtobrutinib vs. Ibrutinib for Patients with Previously Treated Mantle Cell Lymphoma
PortugalStudy on the Effectiveness and Safety of Ralinepag for Patients with Pulmonary Arterial Hypertension
PortugalStudy on the Effectiveness and Safety of Vutrisiran and Patisiran for Patients with Hereditary Transthyretin Amyloidosis
PortugalStudy on the Effectiveness and Safety of Depemokimab vs. Mepolizumab for Adults with Relapsing or Refractory Eosinophilic Granulomatosis with Polyangiitis
PortugalStudy of Pertuzumab and Trastuzumab for Patients with Solid Malignant Tumors from Previous Pertuzumab Trials
PortugalStudy on the Effects and Safety of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy Unresponsive to Usual Treatments
PortugalStudy on Long-term Safety of Seralutinib for Patients with Pulmonary Arterial Hypertension
PortugalThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on pulmonary arterial hypertension and chronic obstructive pulmonary disease, evaluating novel treatments including ralinepag and itepekimab for long-term management of these conditions.
Research investigating treatments for systemic lupus erythematosus, rheumatoid arthritis, and other inflammatory conditions, with studies on medications like upadacitinib and remibrutinib.
Studies examining treatments for multiple sclerosis, migraine prevention, and neurological conditions, testing medications such as ocrelizumab and atogepant.
Investigations into hypertrophic cardiomyopathy and stroke prevention, studying treatments like mavacamten and asundexian for improved cardiac outcomes.
Advanced studies in lung cancer, colorectal cancer, and head and neck cancers, evaluating novel immunotherapy combinations and targeted treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
